Ahmed Rattani
0000-0002-1058-7314
Publication & Citation Trends
Publications
0 total
A phase 2 study of botensilimab and AGEN1423, an anti-CD73-TGFβ-trap bifunctional antibody, in subjects with advanced pancreatic cancer.
Cited by 0
Semantic Scholar
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.
Cited by 0
Semantic Scholar
The Wnt/APC destruction complex targets SREBP2 in a β-catenin-independent pathway to control cholesterol metabolism
Cited by 1
Semantic Scholar
Prognostic Role of MTAP Loss in Cholangiocarcinoma.
Cited by 2
Semantic Scholar
Association between somatic mutation pathways and treatment response in patients with biliary tract cancers (BTCs).
Cited by 0
Semantic Scholar
Abstract A001: An open label, phase II trial of ERK inhibition alone and in combination with autophagy inhibition in patients with metastatic cancreatic cancer
Cited by 1
Semantic Scholar
Research Topics
Genetic Syndromes and Imprinting
(28)
Sarcoma Diagnosis and Treatment
(25)
MicroRNA in disease regulation
(16)
Microtubule and mitosis dynamics
(11)
Kruppel-like factors research
(7)
Affiliations
Mount Auburn Hospital
Beth Israel Deaconess Medical Center
Harvard University
Hadassah Medical Center
University of Oxford